跳至主要内容
临床试验/IRCT20170211032494N4
IRCT20170211032494N4尚未招募1 期

Investigating the tolerability of the diet containing CAPRIDIN in patients with rectal cancer undergoing chemoradiotherapy

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients aged 18 to 75 years old
  • Patients with definitive diagnosis of rectal adenocarcinoma according to histopathology
  • Patients with a Karnofsky score higher than 70
  • Non-metastatic patients
  • Locally advanced patients (T3, T4) N0 or N+
  • Patients with BMI between 18-34

排除标准

  • Patients with metabolic diseases
  • Liver or kidney dysfunction
  • Receiving neoadjuvant chemotherapy
  • Patients who have undergone rectal cancer surgery for any reason
  • Breastfeeding
  • No previous ketogenic diet

研究者

相似试验